Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
March 05, 2024 at 08:47 AM EST
The results add to the growing evidence that the highly popular injection has broader health benefits for patients beyond treating Type 2 diabetes.
